Price range: £120.75 through £327.75
TRH, also known as thyrotropin-releasing hormone, is a TRH peptide that researchers use to investigate thyroid-axis signaling and neuroendocrine control in laboratory environments. It is a tripeptide produced in the hypothalamus that initiates the release of thyrotropin (TSH) from the pituitary gland. Because the TRH peptide operates at the top level of the endocrine cascade, it enables precise modeling of regulatory control within the hypothalamic–pituitary–thyroid axis.
Scientists value the TRH peptide for its clear and measurable biological effects. It supports studies on hormone-feedback loops, receptor-specific activation, and intracellular signaling mechanisms that govern metabolic processes. Additionally, TRH offers researchers the ability to compare native hypothalamic signals with downstream hormonal responses, helping map how endocrine communication adapts under controlled experimental conditions.
Researchers often use the TRH peptide to support:
Mapping TSH-release dynamics in vitro or ex vivo
Analysing hypothalamic–pituitary endocrine feedback
Evaluating neuroendocrine signaling models
Comparing structure-activity relationships among regulatory peptides
Because the TRH peptide delivers consistent receptor engagement and well-defined activity windows, it supports reproducible mechanistic research. It fits programs requiring accurate timing, precise dosing, and reliable repeatability across assays and experiments.
Our TRH peptide is supplied as a high-purity laboratory reagent intended strictly for use by qualified scientific professionals. It is not approved for clinical, therapeutic, diagnostic, or veterinary use. All research involving TRH must comply with institutional safety practices and regulatory guidelines.
For research use only. Not for human consumption.
Discount Applied Successfully!
Your savings have been added to the cart.
